Skip to main content

Table 1 Studies included in analysis

From: Discovering gene expression signatures responding to tyrosine kinase inhibitor treatment in chronic myeloid leukemia

Study GEO dataset The number of samples Cell type/Tissue Drug Platform
Responder Non-responder
McWeeney et al., 2010 [15] GSE14671 41 18 CD34+ cell/BM Imatinib HG-U133_Plus_2
Crossman et al., 2005 [6] GSE2535 16 12 White cell/Blood, BM Imatinib HG-U95Av2
Silveira et al., 2013 [16] GSE33224 6 8 PBMC/Peripheral Blood Dasatinib Agilent-014850